A multicenter, randomized, controlled study to investigate extending the time for thrombolysis in emergency neurological deficits with intra-arterial therapy (EXTEND-IA)

International Journal of Stroke

Volumn 9, Issue 1, 2014, Pages 126-132

  Campbell, Bruce C V ^a   Mitchell, Peter J ^b   Yan, Bernard ^a   Parsons, Mark W ^c   Christensen, Søren ^b   Churilov, Leonid ^a   Dowling, Richard J ^b   Dewey, Helen ^d   Brooks, Mark ^d   Miteff, Ferdinand ^c,e   Levi, Christopher ^c   Krause, Martin ^e   Harrington, Timothy J ^e   Faulder, Kenneth C ^e   Steinfort, Brendan S ^e   Kleinig, Timothy ^f   Scroop, Rebecca ^f   Chryssidis, Steve ^f   Barber, Alan ^g   Hope, Ayton ^g   Moriarty, Maurice ^g   Mcguinness, Ben ^g   Wong, Andrew A ^h   Coulthard, Alan ^h   Wijeratne, Tissa ⁱ   Lee, Andrew ^j   Jannes, Jim ^k   Leyden, James ^l   Phan, Thanh G ^m   Chong, Winston ^m   Holt, Michael E ^m   Chandra, Ronil V ^m   Bladin, Christopher F ^m   Badve, Monica ⁿ   Rice, Henry ⁿ   de Villiers, Laetitia ⁿ   Ma, Henry ^a,m   Desmond, Patricia M ^b   Donnan, Geoffrey A ^a   Davis, Stephen M ^a   more..

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d AUSTIN HOSPITAL   (Australia)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

^f ROYAL ADELAIDE HOSPITAL   (Australia)

^g UNIVERSITY OF AUCKLAND   (New Zealand)

^h ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

ⁱ WESTERN HOSPITAL   (Australia)

^j FLINDERS MEDICAL CENTRE   (Australia)

^k QUEEN ELIZABETH HOSPITAL   (Australia)

^l LYELL MCEWIN HOSPITAL   (Australia)

^m MONASH UNIVERSITY   (Australia)

ⁿ GOLD COAST UNIVERSITY HOSPITAL   (Australia)

more..

Author keywords

CT perfusion; Intra arterial therapy; Ischemic stroke; Mechanical clot retrieval; Solitaire stentriever device; Thrombolysis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN PERFUSION; CIRCULATION TIME; CLINICAL ASSESSMENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; EXTENDING THE TIME FOR THROMBOLYSIS IN EMERGENCY NEUROLOGICAL DEFICITS WITH INTRAARTERIAL THERAPY; FUNCTIONAL STATUS; HUMAN; INTENTION TO TREAT ANALYSIS; INTERNAL CAROTID ARTERY OCCLUSION; INTRAARTERIAL DRUG ADMINISTRATION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; RECANALIZATION; REPERFUSION; STROKE PATIENT; VASCULAR EQUIPMENT;

CT PERFUSION; INTRA-ARTERIAL THERAPY; ISCHEMIC STROKE; MECHANICAL CLOT RETRIEVAL; SOLITAIRE STENTRIEVER DEVICE; THROMBOLYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; RESEARCH DESIGN; STROKE; THROMBECTOMY; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84890860259     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12206     Document Type: Article

References (39)

1. Lees KR, Bluhmki E, von Kummer R etal. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375:1695-1703.
2. Bhatia R, Hill MD, Shobha N etal. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke. Real-world experience and a call for action. Stroke 2010; 41:2254-2258.
3. Saqqur M, Uchino K, Demchuk AM etal. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38:948-954.
4. Broderick JP, Palesch YY, Demchuk AM etal. Endovascular therapy after intravenous t-PA versus t-PA Alone for stroke. N Engl J Med 2013; 368:893-903.
5. Ciccone A, Valvassori L, Nichelatti M etal. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368:904-913.
6. Parsons MW, Christensen S, McElduff P etal. Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab 2010; 30:1214-1225.
7. Yoo AJ, Verduzco LA, Schaefer PW, Hirsch JA, Rabinov JD, Gonzalez GG. MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke 2009; 40:2046-2054.
8. Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009; 73:1066-1072.
9. Ribo M, Flores A, Rubiera M etal. Extending the time window for endovascular procedures according to collateral pial circulation. Stroke 2011; 42:3465-3469.
10. Pereira VM, Gralla J, Davalos A etal. Prospective, multicenter, single-arm study of mechanical thrombectomy using Solitaire flow restoration in acute ischemic stroke. Stroke 2013; ePub 1 Aug 2013 doi: 10.1161/STROKEAHA.113.001232.
11. Saver JL, Jahan R, Levy EI etal. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 380:1241-1249.
12. Miteff F, Levi CR, Bateman GA, Spratt N, McElduff P, Parsons MW. The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke. Brain 2009; 132(Pt 8):2231-2238.
13. Campbell BCV, Christensen S, Tress B etal. Failure of collateral blood flow is associated with infarct growth in ischemic stroke. J Cereb Blood Flow Metab 2013; 33:1168-1172.
14. Parsons MW, Barber PA, Chalk J etal. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002; 51:28-37.
15. Davis SM, Donnan GA, Parsons MW etal. Effects of alteplase beyond 3h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008; 7:299-309.
16. Olivot JM, Mlynash M, Thijs VN etal. Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE). Stroke 2008; 39:2257-2263.
17. Barber PA, Darby DG, Desmond PM etal. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998; 51:418-426.
18. Albers GW, Thijs VN, Wechsler L etal. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60:508-517.
19. Lansberg MG, Straka M, Kemp S etal. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 2012; 11:860-867.
20. Mishra NK, Albers GW, Davis SM etal. Mismatch-based delayed thrombolysis: a meta-analysis. Stroke 2010; 41:e25-33.
21. Campbell BCV, Christensen S, Foster SJ etal. Visual assessment of perfusion-diffusion mismatch is inadequate to select patients for thrombolysis. Cerebrovasc Dis 2010; 29:592-596.
22. Fiebach JB, Al-Rawi Y, Wintermark M etal. Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase. Stroke 2012; 43:1561-1566.
23. Warach S, Al-Rawi Y, Furlan AJ etal. Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials. Stroke 2012; 43:2313-2318.
24. Kidwell CS, Jahan R, Gornbein J etal. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 68:914-923.
25. Christensen S, Campbell BCV, Perez de la Ossa N etal. Optimal perfusion thresholds for prediction of tissue destined for infarction in the combined EPITHET and DEFUSE dataset. Stroke 2010; 41:e297.
26. Olivot JM, Mlynash M, Thijs VN etal. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke 2009; 40:469-475.
27. Zaro-Weber O, Moeller-Hartmann W, Heiss WD, Sobesky J. Maps of time to maximum and time to peak for mismatch definition in clinical stroke studies validated with positron emission tomography. Stroke 2010; 41:2817-2821.
28. Christensen S, Parsons MW, De Silva DA etal. Optimal mismatch definitions for detecting treatment response in acute stroke. Cerebrovasc Dis 2008; 25(Suppl. 2):33.
29. Chemmanam T, Campbell BCV, Christensen S etal. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch. Neurology 2010; 75:1040-1047.
30. Campbell BCV, Purushotham A, Christensen S etal. The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab 2012; 32:50-56.
31. Campbell BCV, Christensen S, Levi CR etal. Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke 2011; 42:3435-3440.
32. Campbell BCV, Christensen S, Levi CR etal. Comparison of computed tomography perfusion and magnetic resonance imaging perfusion-diffusion mismatch in ischemic stroke. Stroke 2012; 43:2648-2653.
33. Straka M, Albers GW, Bammer R. Real-time diffusion-perfusion mismatch analysis in acute stroke. J Magn Reson Imaging 2010; 32:1024-1037.
34. Parsons MW, Spratt N, Bivard A etal. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med 2012; 366:1099-1107.
35. Campbell BC, Tu HT, Christensen S etal. Assessing response to stroke thrombolysis: validation of 24-hour multimodal magnetic resonance imaging. Arch Neurol 2012; 69:46-50.
36. Wintermark M, Albers GW, Broderick JP etal. Acute stroke imaging research roadmap II. Stroke 2013; 44:2628-2639.
37. Wahlgren N, Ahmed N, Davalos A etal. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369:275-282.
38. Mehta CR, Pocock SJ. Adaptive increase in sample size when interim results are promising: a practical guide with examples. Stat Med 2011; 30:3267-3284.
39. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist 1979; 6:65-70.